Advisory Research Inc Amgen Inc Transaction History

Advisory Research Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $26,019 - $32,303	-119 Reduced 8.31%	1,313 $352,000
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $306,834 - $362,825	1,432 New	1,432 $317,000
Q1 2021 May 12, 2021	SELL	$221.91 - $258.6 $1.44 Million - $1.68 Million	-6,487 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $121,605 - $144,810	-562 Reduced 7.97%	6,487 $1.49 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $253,891 - $282,347	-1,082 Reduced 13.31%	7,049 $1.79 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $320,650 - $393,481	-1,621 Reduced 16.62%	8,131 $1.92 Million
Q1 2020 May 12, 2020	BUY	$182.24 - $241.7 $57,041 - $75,652	313 Added 3.32%	9,752 $1.98 Million
Q4 2019 Feb 11, 2020	SELL	$189.21 - $243.2 $105,768 - $135,948	-559 Reduced 5.59%	9,439 $2.28 Million
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $23,678 - $28,372	-136 Reduced 1.34%	9,998 $1.94 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $1.69 Million - $1.98 Million	10,134 New	10,134 $1.87 Million

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

Stay updated on Advisory Research Inc with notifications on news.